367 related articles for article (PubMed ID: 24659226)
21. Lessons learnt from MDM2 fluorescence in-situ hybridisation analysis of 439 mature lipomatous lesions with an emphasis on atypical lipomatous tumour/well-differentiated liposarcoma lacking cytological atypia.
Vargas AC; Joy C; Cheah AL; Jones M; Bonar F; Brookwell R; Garrone B; Talbot J; Harraway J; Gill AJ; Maclean FM
Histopathology; 2022 Jan; 80(2):369-380. PubMed ID: 34523152
[TBL] [Abstract][Full Text] [Related]
22. Anisometric cell lipoma: Insight from a case series and review of the literature on adipocytic neoplasms in survivors of retinoblastoma suggest a role for RB1 loss and possible relationship to fat-predominant ("fat-only") spindle cell lipoma.
Agaimy A
Ann Diagn Pathol; 2017 Aug; 29():52-56. PubMed ID: 28807343
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.
Weaver J; Downs-Kelly E; Goldblum JR; Turner S; Kulkarni S; Tubbs RR; Rubin BP; Skacel M
Mod Pathol; 2008 Aug; 21(8):943-9. PubMed ID: 18500263
[TBL] [Abstract][Full Text] [Related]
24. Update on Lipomatous Tumors with Emphasis on Emerging Entities, Unusual Anatomic Sites, and Variant Histologic Patterns.
Chrisinger JSA
Surg Pathol Clin; 2019 Mar; 12(1):21-33. PubMed ID: 30709444
[TBL] [Abstract][Full Text] [Related]
25. Lipomas of the Oral Cavity: Utility of MDM2 and CDK4 in Avoiding Overdiagnosis as Atypical Lipomatous Tumor.
Stojanov IJ; Mariño-Enriquez A; Bahri N; Jo VY; Woo SB
Head Neck Pathol; 2019 Jun; 13(2):169-176. PubMed ID: 29748845
[TBL] [Abstract][Full Text] [Related]
26. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T
Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516
[TBL] [Abstract][Full Text] [Related]
27. MDM2 Amplification in Problematic Lipomatous Tumors: Analysis of FISH Testing Criteria.
Clay MR; Martinez AP; Weiss SW; Edgar MA
Am J Surg Pathol; 2015 Oct; 39(10):1433-9. PubMed ID: 26146760
[TBL] [Abstract][Full Text] [Related]
28. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours.
Dei Tos AP; Doglioni C; Piccinin S; Sciot R; Furlanetto A; Boiocchi M; Dal Cin P; Maestro R; Fletcher CD; Tallini G
J Pathol; 2000 Apr; 190(5):531-6. PubMed ID: 10727978
[TBL] [Abstract][Full Text] [Related]
29. Atypical lipomatous tumor/"well-differentiated liposarcoma" of the skin clinically presenting as a skin tag: clinicopathologic, immunohistochemical, and molecular analysis of 2 cases.
Paredes BE; Mentzel T
Am J Dermatopathol; 2011 Aug; 33(6):603-7. PubMed ID: 21358383
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic Utility Of Fish For MDM2 In Adipocytic Neoplasms.
Sarwar S; Mushtaq S; Hassan U; Maqbool H; Qazi R
J Ayub Med Coll Abbottabad; 2021; 33(4):563-567. PubMed ID: 35124908
[TBL] [Abstract][Full Text] [Related]
31. Intra-Abdominal and Retroperitoneal Benign Lipomatous Tumors-An Extremely Rare Mimic of Liposarcoma and its Diagnostic Challenge.
Malik F; Allbee AW; Zhang PJ
Int J Surg Pathol; 2024 Feb; 32(1):46-57. PubMed ID: 37131332
[No Abstract] [Full Text] [Related]
32. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas.
Saâda-Bouzid E; Burel-Vandenbos F; Ranchère-Vince D; Birtwisle-Peyrottes I; Chetaille B; Bouvier C; Château MC; Peoc'h M; Battistella M; Bazin A; Gal J; Michiels JF; Coindre JM; Pedeutour F; Bianchini L
Mod Pathol; 2015 Nov; 28(11):1404-14. PubMed ID: 26336885
[TBL] [Abstract][Full Text] [Related]
33. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
[TBL] [Abstract][Full Text] [Related]
34. MDM4 amplification in atypical lipomatous tumors/well-differentiated liposarcoma: Private event or alternative oncogenic mechanism?
Gruel N; El Zein S; Tzanis D; Nicolas N; Maraval A; Fieffe C; Bonvalot S; Caly M; Fuhrmann L; Ait Rais K; Jovelin S; Bonnet C; Pierron G; Watson S
Genes Chromosomes Cancer; 2023 Jun; 62(6):367-372. PubMed ID: 36744846
[TBL] [Abstract][Full Text] [Related]
35. [Clinical value of fluorescence
Wang W; Li X; Liu P; Dong Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132
[TBL] [Abstract][Full Text] [Related]
36. Atypical Spindle Cell/Pleomorphic Lipomatous Tumor.
Qorbani A; Horvai A
Surg Pathol Clin; 2024 Mar; 17(1):97-104. PubMed ID: 38278611
[TBL] [Abstract][Full Text] [Related]
37. Spindle Cell Lipoma with Ossification Mimicking Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma: A Case Report.
Ichikawa J; Kawasaki T; Imada H; Enomoto A; Taniguchi N; Tatsuno R; Kanno S; Haro H
Int J Surg Pathol; 2022 Jun; 30(4):413-418. PubMed ID: 34812072
[TBL] [Abstract][Full Text] [Related]
38. Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?
Alshenawy H
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1073-81. PubMed ID: 23529275
[TBL] [Abstract][Full Text] [Related]
39. Negative MDM2/CDK4 immunoreactivity does not fully exclude MDM2/CDK4 amplification in a subset of atypical lipomatous tumor/ well differentiated liposarcoma.
Machado I; Vargas AC; Maclean F; Llombart-Bosch A
Pathol Res Pract; 2022 Apr; 232():153839. PubMed ID: 35303521
[TBL] [Abstract][Full Text] [Related]
40. Differential diagnosis of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma by cytological analysis.
Sugiyama K; Washimi K; Sato S; Hiruma T; Sakai M; Okubo Y; Miyagi Y; Yokose T
Diagn Cytopathol; 2022 Mar; 50(3):112-122. PubMed ID: 34984861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
